COATS LONNEL
SEC insider (Form 3/4/5 filer). CIK 0001612528. Director at Mineralys Therapeutics, Inc. (MLYS) and 3 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Oct 19, 2026. Located in RADNOR, PA.
Companies COATS LONNEL has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Director
- Relay Therapeutics, Inc. (RLAY): Director
- Verve Therapeutics, Inc. (VERV): Director
- Blueprint Medicines Corp (BPMC): Director
COATS LONNEL
CIK: 0001612528
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Oct 19, 2026MLYS
Mineralys Therapeutics, Inc.
AwardDirect12.4K shares- - Jun 9, 2026RLAY
Relay Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32.9K shares- - Nov 4, 2025RLAY
Relay Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
207.9K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
42.2K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
136.1K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
DispositionDirect6.1K shares- - Jun 18, 2025BPMC
Blueprint Medicines Corp
AwardDirect3.9K shares at avg. $12812.00$50.0M - Jun 5, 2025VERV
Verve Therapeutics, Inc.
AwardDirectStock Option (right to buy)
42.2K shares- - Nov 21, 2024BPMC
Blueprint Medicines Corp
SaleDirect9.8K shares at avg. $94.87$932K - Nov 20, 2024BPMC
Blueprint Medicines Corp
SaleDirect213 shares at avg. $94.99$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 |  MLYS Mineralys Therapeutics, Inc. | Award | 12,400 | - | $0 | Direct |
| Jun 9, 2026 |  RLAY Relay Therapeutics, Inc. | Award Stock Option (Right to Buy) | 32,947 | - | - | Direct |
| Nov 4, 2025 | RLAY Relay Therapeutics, Inc. | Award Stock Option (Right to Buy) | 207,931 | - | - | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 42,200 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 136,139 | - | - | Direct |
| Jul 17, 2025 |  BPMC Blueprint Medicines Corp | Disposition | 6,144 | - | - | Direct |
| Jun 18, 2025 | BPMC Blueprint Medicines Corp | Award | 3,902 | $12812.00 | $49,992,424 | Direct |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | Award Stock Option (right to buy) | 42,200 | - | - | Direct |
| Nov 21, 2024 | BPMC Blueprint Medicines Corp | Sale | 9,824 | $94.87 | $932,003 | Direct |
| Nov 20, 2024 | BPMC Blueprint Medicines Corp | Sale | 213 | $94.99 | $20,233 | Direct |
1-10 of 14 transactions